ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,517Medicare Part D Prescriptions Filled, Including Refills

Rank: 634 out of 2061

$656K Total Retail Price of All Prescriptions

Rank: 413 out of 2061

135 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 135 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 135 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 1,665 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SYNTHROID 495 43 1 58
OMEPRAZOLE 401 46 2 5
LACTULOSE 390 0 3 131
CLOZAPINE 278 0 4 164
POLYETHYLENE GLYCOL 3350 278 27 4 64
SIMVASTATIN 217 99 6 1
OLANZAPINE 199 0 7 132
LAMOTRIGINE 189 0 8 186
TOPIRAMATE 148 0 9 190
LISINOPRIL 143 51 10 2
TRAZODONE HCL 143 0 10 39
DIVALPROEX SODIUM 135 0 12 74
DILANTIN 125 0 13 337
DIVALPROEX SODIUM ER 124 0 14 188
CHLORPROMAZINE HCL 123 0 15 378
QUETIAPINE FUMARATE 123 12 15 72
BENZTROPINE MESYLATE 123 12 R 15 149
HALOPERIDOL 121 24 18 153
OXCARBAZEPINE 119 0 19 244
TEGRETOL 116 0 10 20 440
BYSTOLIC 97 0 21 130
AMLODIPINE BESYLATE 94 28 22 4
ZIPRASIDONE HCL 89 0 23 308
FUROSEMIDE 87 43 24 6
ALENDRONATE SODIUM 85 27 25 25
GEODON 83 0 26 468
INVEGA 81 0 27 380
VIMPAT 81 0 27 353
RISPERIDONE 76 0 29 66
METFORMIN HCL 74 24 30 9
METOCLOPRAMIDE HCL 72 0 31 138
PAROXETINE HCL 71 0 32 61
KEPPRA 70 0 33 439
PRAVASTATIN SODIUM 69 20 34 14
FLUTICASONE PROPIONATE 68 14 35 43
CARVEDILOL 66 50 36 22
GEMFIBROZIL 64 11 37 107
TRAMADOL HCL 63 25 38 18
GLIMEPIRIDE 61 26 39 33
LEVETIRACETAM 60 0 40 102
RANITIDINE HCL 58 11 41 53
BROMOCRIPTINE MESYLATE 53 0 42 523
TEGRETOL XR 52 29 43 527
ATORVASTATIN CALCIUM 52 42 43 8
SEROQUEL 50 0 45 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 21, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.